Home

Robert Barrow

CIK 1897557 · Chief Executive Officer · last filed 2026-09-14

Robert Barrow is a Chief Executive Officer who has filed 55 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for DFTX, was dated Sep 14, 2026. Across all open-market trades the lifetime net is −$4.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $87.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$87.11M

Companies

2

Total Filings

55

Lifetime Open-Market Net

-$4.26M

Filer Profile

Reported Address
C/O MIND MEDICINE INC.
ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK, NY 10007
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DFTX Chief Executive Officer 2,244,640 $38.81 $87.11M -$2.49M 7 2026-09-14
Definium Therapeutics, Inc. (MNMD) Delisted Chief Executive Officer 778,477 $15.00 $11.68M -$1.77M 35 2025-12-29

Recent Filings

55 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-14 DFTX Grant (A) +750,000 $0 EDGAR
2026-09-04 DFTX Mixed +20,977 -$721.7K EDGAR
2026-09-03 DFTX Notice (144) −19,023 -$718.1K EDGAR
2026-08-12 DFTX Grant (A) +375,000 $0 EDGAR
2026-06-26 DFTX Sell (S) −29,208 -$1.32M EDGAR
2026-06-25 DFTX Notice (144) −29,208 -$1.23M EDGAR
2026-06-22 DFTX Grant (A) +375,000 $0 EDGAR
2026-03-26 DFTX Sell (S) −24,431 -$451.2K EDGAR
2026-03-25 DFTX Notice (144) −24,431 -$451.2K EDGAR
2026-02-05 DFTX Grant (A) +320,000 $0 EDGAR
Showing 1–10 of 55
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.